ALK-Abelló A/S
ALK-B
Rangering i aksjer
#2340
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Aksjekurs
$37.79
Markedsverdi
$8.38B
Endring (1 dag)
0.00%
Endring (1 år)
12.73%
Land
DK
Handel ALK-Abelló A/S (ALK-B)
Kategori
Healthcare
Utbyttehistorikk for ALK-Abelló A/S (ALK-B)
ALK-Abelló A/S (aksjesymbol: ALK-B) har gitt totalt 19 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $24.82
Utbytteavkastning (TTM): 0.0071
Summen av alle utbytter (justert for aksjesplitt): $24.82
Utbytteavkastning (TTM): 0.0071
Utbyttebetalinger for ALK-Abelló A/S (ALK-B) fra 2000 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.25 | 0.00% |
| 2017 | $0.25 | 0.00% |
| 2016 | $0.25 | 0.00% |
| 2015 | $0.25 | 0.00% |
| 2014 | $0.25 | 0.00% |
| 2013 | $0.25 | 0.00% |
| 2012 | $0.25 | 0.00% |
| 2011 | $0.25 | 0.00% |
| 2010 | $0.25 | 0.00% |
| 2009 | $0.25 | -84.85% |
| 2008 | $1.65 | 1,550.00% |
| 2007 | $0.1 | -60.00% |
| 2006 | $0.25 | -98.75% |
| 2005 | $20.00 | 19,896.50% |
| 2004 | $0.1 | 0.00% |
| 2003 | $0.1 | 0.00% |
| 2002 | $0.1 | 0.00% |
| 2001 | $0.1 | -42.86% |
| 2000 | $0.175 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $5.00 | 0.00% |
| 2017 | $5.00 | 0.00% |
| 2016 | $5.00 | 0.00% |
| 2015 | $5.00 | 0.00% |
| 2014 | $5.00 | 0.00% |
| 2013 | $5.00 | 0.00% |
| 2012 | $5.00 | 0.00% |
| 2011 | $5.00 | 0.00% |
| 2010 | $5.00 | 0.00% |
| 2009 | $5.00 | -84.85% |
| 2008 | $33.00 | 1,550.00% |
| 2007 | $2.00 | -60.00% |
| 2006 | $5.00 | -98.75% |
| 2005 | $399.93 | 19,896.50% |
| 2004 | $2.00 | 0.00% |
| 2003 | $2.00 | 0.00% |
| 2002 | $2.00 | 0.00% |
| 2001 | $2.00 | -42.86% |
| 2000 | $3.50 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
